Selected for HVC Kyoto 2025

Our AI-driven drug discovery platform, KumiChem™, has been selected by HVC Kyoto 2025, a leading healthcare venture conference in Japan that connects cutting-edge startups with investors, industry leaders, and global partners to accelerate innovation in life sciences.